Anna Eramo
Affiliations: |
Google:
"Anna Eramo"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Andrea de Bartolomeis | post-doc | 2001-2003 | University School of Medicine of Naples Federico II Italy |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wong DF, Chand GB, Caito N, et al. (2024) PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
| Barone A, De Simone G, Ciccarelli M, et al. (2023) A Postsynaptic Density Immediate Early Gene-Based Connectome Analysis of Acute NMDAR Blockade and Reversal Effect of Antipsychotic Administration. International Journal of Molecular Sciences. 24 |
| Iasevoli F, Buonaguro EF, Avagliano C, et al. (2020) The Effects of Antipsychotics on the Synaptic Plasticity Gene Depend on a Combination of Their Receptor Profile, Dose, Duration of Treatment, and Brain Regions Targeted. International Journal of Molecular Sciences. 21 |
| van Erp TG, Baker RA, Cox K, et al. (2020) Effect of brexpiprazole on control of impulsivity in schizophrenia: A randomized functional magnetic resonance imaging study. Psychiatry Research. Neuroimaging. 301: 111085 |
| Correll CU, Shi L, Weiss C, et al. (2018) Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians' choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study. Cns Spectrums. 1-11 |
| Salzman PM, Raoufinia A, Legacy S, et al. (2017) Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole. Neuropsychiatric Disease and Treatment. 13: 1125-1129 |
| Naber D, Baker RA, Eramo A, et al. (2017) Long-term effectiveness of aripiprazole once-monthly for schizophrenia is maintained in the QUALIFY extension study. Schizophrenia Research |
| Ismail Z, Peters-Strickland T, Miguelez M, et al. (2017) Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores. Journal of Clinical Psychopharmacology |
| Maletic V, Eramo A, Gwin K, et al. (2017) The Role of Norepinephrine and Its α-Adrenergic Receptors in the Pathophysiology and Treatment of Major Depressive Disorder and Schizophrenia: A Systematic Review. Frontiers in Psychiatry. 8: 42 |
| Potkin SG, Loze JY, Forray C, et al. (2017) Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY. International Clinical Psychopharmacology |